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ABSTRACT
Effects of an Antiestrogen and Estradiol on Food Intake,
Body Composition, and Metabolism in Ovar iectomized Rats'
February 1984
Henry W. Heller, B.S., University of Scranton
M.S., University of Massachusetts
Directed by: Professor George N. Wade
In ovariectomized rats receiving daily injections for
35 days the effects of oil or of 10 ug of TAM did not
differ significantly, but 50 ug, 250 ug, and 1000 ug of
TAM all produced significant reductions of total food
intake, percent body weight, and carcass fat.
Ovariectomized rats deprived of food for five hours
daily and receiving daily injections for 35 days of oil or
of 2 ug of estradiol benzoate (EE) showed no difference in
total food intake, although animals receiving 250 ug of
TAM or 2 ug of EB and 250 ug of TAM showed significant
reductions. Animals receiving EB, TAM or TAM+EB showed
significant reductions of percent body weight, carcass
fat, and parametrial white adipose tissue weight and lipo-
protein lipase activity. In interscapular brown adipose
tissue EB did not have an affect, but TAM produced in-
creases in weight and protein which were reversed by EB.
EB and TAM+EB increased oxygen consumption on the first
iv
day after the initial injection, but subsequently oxygen
consumption decreased. TAM produced an initial increase in
oxygen consumption which then remained relatively
elevated.
In ovariectomized rats receiving oil injections a
five-hour daily food deprivation produced a dramatic re-
duction in total food intake and a decrease in body weight
compared to animals receiving oil on ad lib , food. Five-
hour daily deprivation attenuated the EB-induced reduction
of total food intake and body weight. Five-hour daily
food deprivation had no effect on food intake or body
weight in rats receiving TAM. Drugs and food manipula-
tions produced no significant effects on oxygen con-
sumption, but the patterns shown by TAM and by EB closely
resembled those shown in the previous experiment. In
animals receiving ad lib , food EB produced a continued
elevation, while .oil and TAM did not differ.
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CHAPTER I
INTRODUCTION
Seventy years ago Stotsenburg (1913) showed that bi-
lateral ovariectomy increased food intake, body weight and
body length in rats. He ascertained that the increased
length was not sufficient to account for the increased
weight and attributed the additional increase to fat (al-
though he did not measure the body fat). He also found
that unilateral ovariectomy had no effect on food intake,
body weight, or body length but did produce hypertrophy of
the remaining ovary. Subsequently Wang, Richter, and
Guttmacher (1925) established that implanting ovaries in
castrate male rats led to a decrease in food intake.
These studies suggested that a substance secreted by the
ovaries could produce a reduction in food intake and body
weight. Bugbee and Simond (1926) demonstrated that an
extract made from ovaries reduced weight gain in ovariec-
tomized rats, and Bogart, Lasley, and Mayer (1944) estab-
lished that giving estrone to ovar iectomized rats reversed
the increase in food intake and body weight. These
findings have been replicated frequently with both peri-
pheral and hypothalamic applications of estrogens (for
review see Wade, 1976).
1
2Stotsenburg (1913) speculated that the weight gain
from ovariectomy was partly attributable to an increase of
fat deposition. Holt, Keeton, and Vennesland (1936) found
that there was an increase of bone length following ovari-
ectomy but failed to find any changes in the chemical
composition of the body. Leshner and Collier (1973) as-
certained that ovariectomy produced increases in fat con-
tent of female rats but did not have an effect on protein
content. Several subsequent studies have produced simi-
lar findings and indicated that estradiol counteracts this
increase (see, for example, Gray & Wade, 1981; Roy & Wade,
1977). Mueller and Hsaio (1981) used the Lee index—
a
measure of obesity which uses body weight and body
length— to confirm that ovar iectomized rats became more
obese and that estradiol treatment, while not returning
already heavy rats to the weights of controls, returned
them to weights that were consistent with their increased
length. They estimated that about 40% of the increased
weight was due to increased skeletal and associated
growth, and the remainder was due to increased fat. Sim-
son, Jones, Schwarz, and Gold (1982) reported that one
group of ovar iectomized rats showed nonsignificant in-
creases in fat compared to intact animals, but that three
other groups of rats all showed increases in fat compared
to intact controls. Other studies suggest that the
3weight gain is attributable to growth only, not an in-
crease in fat deposition. Clark and Tarttelin (1982)
found no difference in fat content of ovar iectomized and
intact rats, but housed the animals in groups, a situation
which can in itself alter food intake and body weight.
Despite some findings to the contrary the preponderance of
evidence suggests that ovariectomy does increase fat con-
tent of the rat.
Roy and Wade (1977) demonstrated that ovar iectomized
rats not receiving estradiol, which were pair-fed with
ovar iectomized rats receiving estradiol, did not lose as
much weight as their pair-feeding partners. Mueller and
Hsaio (1980) reported that ovar iectomized rats which were
restricted to pr eovar iectomy food intake still gained
large amounts of weight. These findings indicate that the
change in food intake alone is not sufficient to produce
the change in body weight. Changes in metabolic rate may
account for changes in body weight that are not attribut-
able to altered food intake. Carlisle, Wilkinson, Lauden-
slager, and Keith (1979) reported a nonsignificant seven
percent increase of metabolic rate as measured by oxygen
consumption in response to estradiol. Laudenslager
,
Wilkinson, Carlisle, and Hammel (1980) reported signifi-
cant increases in heat production as measured by oxygen
4consumption in ovar iectomized rats with estrogen treatment
and decreases following removal of estrogen. They also
determined that restricting activity did not affect this
increase. Laudenslager
,
Carlisle, and Calvano (1982)
found increases in heat production measured by oxygen
consumption at ISOq and at
-50c in estradiol-tr eated
ovar iectomized rats. These reported increases in meta-
bolic rate in response to estradiol could partially ac-
count for the findings of Roy and Wade (1977) and of
Mueller and Hsaio (1980). -
Changes in body weight due to changes in metabolism
may be due to differences in heat production. Brown adi-
pose tissue (BAT) contributes significantly to diet-in-
duced thermogenesis (Rothwell & Stock, 1979) and to non-
shivering thermogenesis in cold-adapted animals (Foster &
Frydman, 1979). Tulp (1981) has shown that removal of
interscapular BAT can lead to increased weight gain and
fat deposition in rats and Connolly, Morrisey, & Carnie
(1982) have shown this in mice. Fatty acids are the
primary fuel for BAT thermogenesis (Nichols, 1979). In-
creases in lipogenesis in BAT are caused by exposure to
cold (Trayhurn, 1979) and by sucrose overfeeding (Granne-
man & Wade, 1983) in rats. Bertin, Goudern, and Portet
(1978) established that the activity of lipoprotein lipase
(LPL)—an enzyme which hydrolyzes triglycerides and per-
5mits fatty acid uptake by the cell— increases in BAT of
rats in response to cold but Granneman and Wade (1983)
showed that it does not increase in response to sucrose
overfeeding
.
Wade and Gray (1978) established that cytoplasmic
estrogen receptors are present in BAT. Edens and Wade
(1983) demonstrated that ovar iectom ized rats receiving
estradiol increase incorporation of tritium into fatty
acids in interscapular BAT. They found no change in BAT
LPL activity with estradiol treatment. These results
suggest that increased BAT thermogenesis may contribute to
the weight loss due to estradiol treatment. The source of
the increased tritium incorporation into BAT is unclear.
It could be due to in situ synthesis or to increased
uptake of fatty acids synthesized elsewhere. Although
Edens and Wade (1983) found no increase in BAT LPL activ-
ity to explain increased uptake, de Gasquet, Planche, and
Boulange (1981) found increases in weight of white adipose
tissue (WAT) in high-fat fed rats along with a decrease in
WAT LPL activity. This suggests that uptake of fatty
acids from triglycerides by tissues can occur by mech-
anisms other than LPL.
The increased synthesis or uptake of fatty acids by
BAT suggests that some redistribution of metabolic fuels
6may occur (Edens & Wade, 1983). One source of these may
be fatty acids from WAT which are released in response to
estradiol. Wade and Gray (1978) demonstrated that Estrogen
receptors also occur in WAT so effects on these tissues
may be direct. Ovariectomy has been found to increase WAT
LPL activity in rats, an effect which is reversed by
estradiol treatment (Edens & Wade, 1983; Gray & Greenwood,
1982; Gray & Wade, 1981; Hamosh & Hamosh, 1975; Ramirez,
1981). Edens and Wade (1983) also demonstrated that es-
tradiol treatment decreased the incorporation of tritium
into WAT fatty acids in rats. Application of estradiol to
the hypothalamus—which does influence food intake—does
not produce changes in WAT LPL activity (Nunez, Gray, &
Wade, 1980). Estradiol also affects hepatic acetyl coen-
zyme A carboxylase (ACC) and fatty acid synthetase (FAS)
(Gray & Greenwood, 1982), two rate limiting enzymes of
lipogenisis, in WAT. Initially both enzymes decrease, but
after one week return to control levels, and after two
weeks are significantly elevated.
Wade and Gray (1979) and Ramirez (1980) have sug-
gested that decreases in fat in WAT and increases in blood
levels of triglycerides following estradiol treatment
(Edens & Wade, 1983; Gray & Greenwood, 1982; Gray & Wade,
1981; Ramirez, 1980, 1981) may represent redistribution of
fatty acid fuels. This suggestion is supported by the
7findings of Ramirez (1980, 1981) that estradiol does not
alter the absolute clearance rates of triglycerides but
does increase the rate of triglyceride clearance by muscle
compared to that by WAT. Other substances which may serve
as fuels are also affected by ovariectomy and estradiol.
Ahmed-Sorour and Baily (1981) reported increased gluconeo-
genisis and reduced glycogen deposition in liver, uterus,
and muscle following ovariectomy. These effects were
reversed with estradiol treatment. Gray and Greenwood
(1982) did not find changes in levels of blood glucose,
however. Gray and Greenwood (1982) and Ramirez (1980)
established that estradiol treatment of ovar iectomized
rats results in an increase of plasma free fatty acids.
Several nonsteroidal "antiestrogens" have been shown
to have estrogenic effects on food intake and body weight
in rats. Roy and Wade (1976, 1977) found reduced food
intake and body weight in ovar iectomized rats in response
to the administration of MER-25. The administration of
MER-25 to the hypothalamus by Roy, Maass, and Wade (1977)
produced similar results. King and Cox (1976) admin-
istered CI-628 peripherally, and Donohoe and Stevens
(1982) administered it to the hypothalamus of ovariec-
tomized rats. Both treatments produced reductions in food
intake and body weight. Several groups have shown reduc-
8tions in food intake and body weight in ovar iectomized
rats in response to peripheral (Gray and Wade, 1981;
Ramirez, 1980; Wade and Blaustein, 1978) or central (T.
Bartness, personal communication) administration of naf-
oxidine. Bowman, Leake, Miller, and Morris (1981) and
Bowman, Leake and Morris (1981) produced reductions in
food intake and body weight in ovar iectomized rats with
peripheral administration of en-clomiphene. Martin (1981)
produced body weight losses in rats with tamoxifen.
Roy and Wade (1977) used pair feeding to demonstrate
that MER-25 produces weight losses which, like those pro-
duced by estradiol, cannot be explained solely by changes
in food intake. Gray and Wade (1981) established that
nafoxidine reduces the amount of fat in ovar iectom ized
rats. Nafoxidine has no effect on plasma free fatty acids
(Ramirez, 1980) but, unlike estradiol, reduces levels of
triglycerides (Gray & Wade, 1981; Ramirez, 1980). Like
estradiol, nafoxidine does produce decreases in WAT LPL
activity (Gray & Wade, 1981).
Tamoxifen is a tr iphenylethylene which is a potent
estrogen antagonist, but which also shows some estrogenic
effects (for review see Furr, ^ alf 1979). Wilking,
Appelgren, Carlstrom, Pousette, and Theve (1982) found by
autoradiography that tamoxifen concentrates in several
tissues including BAT shortly after injection in mice.
9Given this and the presence of estrogen receptors in BAT
(Wade and Gray, 1978) it is possible that tamoxifen may
affect BAT growth and thermogenesis. Martin (1981) showed
that a high dose (5 mg/kg) of tamoxifen suppresses weight
gain in ovar iectomized rats, but unfortunately did not
report food intake.
Different antiestrogens may produce different effects
(see for example, Jordan, Clark, & Allen, 1981). At the
time this study was begun there were indications that
tamoxifen had only antiestrogenic effects (for example,
Dflhler, van zer Mflhlen, and DShler, 1977). It was thus
possible that tamoxifen would not act like other anti-
estrogens on food intake and body weight. Also, because
tamoxifen is becoming commonly used in humans for treat-
ment of cancer, effects of tamoxifen are of considerable
interest.
The purpose of the present studies was to describe
the effects of tamoxifen on food intake and various fac-
tors related to or affecting body weight and composition,
to compare the effects of tamoxifen with those of estra-
diol, and to examine the effects of concurrent administra-
tion of tamoxifen and estradiol.
It is worth noting that tamoxifen and several other
antiestrogens bind to a high-affinity, saturable binding
10
site (the nature and function of which is not yet known)
in many estrogen target tissues (Sutherland, Murphy, Foo,
Green, Whybourne, & Krozowski, 1980) and in many tissues
which do not contain estrogen receptors (Sudo, Monsma, &
Katzenellenbogen, 1983). This site has an extremely low
affinity for estrogens (Sudo, et. al., 1983). Thus inter-
pretation of results when ant iestr ogens are used may be
difficult
.
CHAPTER II
EXPERIMENT 1
The initial question asked was what effect, if any,
tamoxifen alone has on food intake, body weight, and body
composition in ovar iectomized rats.
Methods
Animals
Thirty six female CD rats (Charles Rivers Breeding
Laboratories, Wilmington, MA) were singly housed in
hanging wire-bottom cages with room temperature approx-
imately 22°C and with 12 hours of light per day. Purina
Rodent Chow pellets (#5001) and tap water were available
ad libitum. The rats were bilaterally ovar iectomized
under methoxyflurane anaesthesia (Metofane, Pitman-Moore)
via two lateral incisions. Following ovariectomy the
animals were divided into five groups (n=7 or 8) which
were balanced for body weight and food intake and the
groups were randomly assigned to experimental conditions.
The animals weighed between 227 and 330 grams at the start
of injections 25 days following ovariectomy.
Drugs
Tamoxifen citrate (TAM) (Stuart Pharmaceutical, Wil-
li
12
mington, DE) was dissolved in sesame oil to produce a full
dose in .1 ml.
Procedurp
The rats received daily, subcutaneous injections of
TAM at doses of 0 ug, 10 ug, 50 ug, 250 ug, and 1000 ug
per animal approximately six hours before lights out. At
the time of injections body weight and food intake were
measured. Spillage was collected on papers placed beneath
the cages and weighed daily. Injections and measures of
body weight and food intake continued for 35 days. On the
morning following the last day of injections the animals
were given an overdose of sodium pentobarbital (Nembutal),
shaved, eviscerated, placed in preweighed aluminum foil
baking pans, and weighed in preparation for carcass analy-
sis. A modification (Gray & Wade, 1981) of the method of
Leshner, Litwin, and Squibb (1972) was used to determine
carcass composition. Water and fat were determined gravi-
metrically and protein content was determined by the
method of Lowry, Rosebrough, Farr, and Randall (1951). The
data from one animal receiving 250 ug of tamoxifen which
died were dropped.
Data analysis
Food intake was summed across the experimental period
and the final body weight was calculated as the per cent
13
of the initial body weight. All data were analyzed by
one-way analysis of variance followed by the Duncan's
multiple range test using the Interactive Data Analysis
Package (IDAP) (Wiedman & Hosmer, 1983). Results were con-
sidered significant for e<.05, two-tailed.
Results
weight
TAM significantly decreased the final body weight
expressed as the percent of the initial body weight,
£(4,30) =28.49, e<.0001, an effect which is similar to that
reported for other ant iestr ogens and for estradiol. Per-
cent weights of rats receiving 50 ug or 250 ug of TAM were
lower than those of rats receiving oil or 10 ug of TAM
(which did not differ) and per cent weights of rats re-
ceiving 1000 ug of TAM were lower than those of animals
receiving oil, 10 ug, or 50 ug of TAM (see Figure lA).
Total food intake was also significantly decreased by
TAM, £(4,30)=5.65
, E<.002. Rats receiving 2 50 ug or 1000
ug of TAM ate significantly less than those receiving oil
or 10 ug (which did not differ). Rats receiving 50 ug of
TAM ate less than those receiving oil but did not differ
significantly from those receiving 10 ug of TAM (See
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Figure 1. A. Effect of TAM on final body weight
as percent of initial body weight (mean+standard
error). B. Effect of TAM on total food intake
(mean+standard error).
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Figure IB)
.
Carcass compos it-i,r>n
Because of the differences in body weight among
groups different ways of expressing the body components
produced slightly different results. with the exception
of protein the effects of TAM on carcass composition were
similar to those previously reported for estrogens (See
Table 1).
The effect of TAM on water expressed in grams was
short of significance, £(4,30) =2.06, £=.11, although 1000
ug of TAM reduced grams of water relative to oil. The
effect of TAM on water as a percent of wet weight was
significant, F ( 4 , 3 0 ) =3 .9 2 , p<.02 with TAM at 50 ug, 250
ug, or 1000 ug producing an increase in percent water
compared to oil or 10 ug of TAM (which did not differ
significantly). TAM had a significant effect on fat
whether expressed as grams, F(4,30) =7.95, p<.001, as per-
cent of wet weight, F(4,30) =5.08, p<.01, or as percent of
dry weight. £(4,30) =6.08, p<.001. In each case the oil
and the 10 ug TAM groups had more fat than the other three
groups.
'The effect of TAM on protein was not significant
regardless of how protein was expressed, although 1000 ug
of TAM did produce an increase of protein expressed as a
16
percent of dry weight relative to the oil group.
Table 1. Rat carcass composition from Experiment 1 showing
weight in grams, percent of carcass wet weight (wet per-cent), and percent of carcass dry weight (drvpercent) (mean±standard error).
Dose of Tamoxifen
Water
0 ug
(n=7)
10 ug
(n=7)
50 ug
(n=7)
250 ug
(n=7)
1000 ug
(n=7)
grams 174.7
±5.3
168.0
±4.2
161.9
±3.2
157.8
±3.0
^150.8
±1.7
wet percent
Fat
58.4
±1.2
59.3
±1.3
^61.
8
±0.9
^62.
2
±0.9
b62.6
±0.4
grams 53.9
±5.3
47.5
±4 .
2
•^35.0
+3 .2
•^32.7
+ 3 0
•^30.6
+ 1 7
wet percent 18.1
±1.4
16.7
±1.3
•^13.3
±1.0
^12.
9
±1.1
^12.
7
±0.6
dry percent
Protein
43.1
±2.4
40.7
±1.7
^34.
5
±1.8
^33.
±2.2
^^32.
6
±1.5
grams 37.8
±2.4
37.0
±2.7
32.7
±2.2
31.0
±1.7
33.0
±1.6
wet percent 12.7
±0.3
13.0
±0.6
12.5
±0.8
12.2
±0.7
13.7
±0.6
dry percent 30.7
±1.1
32.1
±2.0
32.8
±1.9
32.6
±2.2
^36.7
±1.6
a. differs from 0 ug, e<.05.
differs from 0 ug and 10 ug, p<.05
CHAPTER III
EXPERIMENT 2
Experiment 1 showed that TAM produced effects on food
intake and on body weight and composition which are simi-
lar to those produced by other a nt i e s t r ogens and by EB.
The next step in describing the effects of TAM was to
compare the effects of TAM with those of estradiol ben-
zoate (EB) and to explore for antagonistic effects by the
concurrent administration of TAM and EB. Because of
reported effects of ovariectomy and estrogens on energy
balance (Laudenslager
, et al, 1980) resting oxygen con-
sumption was measured as were the effects of TAM and EB on
WAT and on BAT. Uterine weight was used as a bioassay for
the antiestrogenic activity of TAM as TAM alone produces
only slight increases in uterine weight and TAM antago-
nizes EB-induced increases in uterine weight (Harper &
Walpole, 1967).
Methods
Animals were treated as in Experiment 1 except as
noted below. Following ovariectomy the animals were
divided into four groups (n=9) which were balanced for
17
18
body weight and food intake, and the groups were randomly
assigned to experimental conditions. The animals weighed
between 221 and 282 grams at the start of injections 16
days following ovariectomy.
Dcugs
Tamoxifen citrate (Stuart Pharmaceutical, Wilmington,
DE) and estradiol benzoate (EB, Schering Corporation,
Bloomfield, NJ) were dissolved in sesame oil to produce a
full dose in .1 ml.
Procedure
The animals received daily, subcutaneous injections
of oil, 2 ug EE, 250 ug TAM, or 250 ug TAM plus 2 ug EE
(TAM+EE) per animal approximately six hours before lights-
out. Daily measures of food intake and body weight were
made at this time.
The animals were divided into three groups composed
of equal numbers of animals from each experimental group.
Injections began on three consecutive days and all mea-
sures were recorded in terms of number of days of
injections.
Prior to initiation of injections and throughout this
experiment food was removed from the animals approximately
six hours prior to lights-out and returned one hour prior
to lights-out. Food was available libitum at all other
19
times. water was available li^iiiim at all times
throughout the experiment.
Prior to initiation of the injections all animals
were adapted to the Plexiglas chambers used for measuring
oxygen consumption for 30 minutes per day for seven days.
Oxygen consumption was measured between one and three
hours prior to lights out. Resting oxygen consumption
was measured by placing a conscious animal in an airtight
Plexiglas chamber connected by tubing to an Applied Elec-
trochemistry S3-A oxygen analyzer. Air passed through the
chamber, through soda lime to remove carbon dioxide, and
through calcium sulfate (Dririte) to remove water before
entering the analyzer. A flow rate of 750 ml/min was used
and the analyzer was calibrated to 20.94% oxygen for room
air. The percent of oxygen in the chamber air was read
from the oxygen analyzer. The animal was in the chamber
for five minutes before readings were taken to prevent
interference by room air. The values used for calcula-
tions were the two highest values obtained (minimum con-
sumption) with the animals resting with the requirements
that a period of activity occurred between the readings
and that they did not differ by more than .05 units. The
mean of these two values was subtracted from 20.94 and the
result multiplied by 7.5 to determine absolute consumption
20
in ml oxygen/min. This value was divided by the body
weight in kg raised to the .75 power.
On the day before injections began and on the final
day of injections the animals were anaesthetized (Meto-
fane, Pi tman- Moor e) and the naso-anal length was deter-
mined with the animals stretched by a 135 g weight. On
the morning following the last day of injections, the
animals were given an overdose of sodium pentobarbital
(Nembutal) and prepared for carcass analysis as described
in Experiment 1. At this time parametrial white adipose
tissue, intr ascapular brown adipose tissue, and uterus
were removed and weighed to the nearest .1 mg. The weight
of the WAT was added to the carcass wet and dry weights
and to the lipid weight for each animal. One animal in
the EB group died during the night following the last
injection. Data from this animal for food intake, body
weight, naso-anal length, and oxygen consumption are in-
cluded in the results, but data on body components were
not obtained.
WAT and BAT were homogenized and frozen for later
analysis of LPL activity by a modification (Hietanen &
Greenwood, 1977; Gray & Wade, 1981) of the method of
Schotz, Garfinkel, Huebotter, and Stewart (1970). An ali-
quot of homogenized BAT solution was placed in 5 ml etha-
nol for subsequent protein and DNA determination. Protein
21
was measured by the method of Lowry, et. al. (1951) and
DNA by the method of Burton (1956).
Data analysis
Total food intake, final body weight expressed as per
cent of initial body weight, and carcass composition were
calculated and expressed as in Experiment 1. The data
were analyzed by one-way analysis of variance followed by
the Duncan's multiple range test using IDAP (Wiedman &
Hosmer, 1983), except oxygen consumption which was ana-
lyzed with a repeated measures ANOVA using BMDP4V, and Lee
index which was analyzed with the Kr uskal-Wall is test
using IDAP. A value of p<.05, two-tailed, was considered
significant.
As had been expected treatment significantly reduced
the final body weight expressed as percent of initial body
weight, £(3,32) =77.06, p<.0001. Percent weights of rats
receiving TAM or TAM+EB were lower than those of rats
receiving EB or oil. Percent weights of rats receiving EB
were significantly lower than were those of rats receiving
oil only (Figure 2A). The weights of all three groups
receiving drugs were reduced by the fourth day of injec
140r
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Figure 2. A. Effects of drugs on final body
weight as percent of initial body weight
(mean+standar d error). B. Effects of drugs on
total food intake (mean+standard error).
Figure 3, A, Effects of drugs on body weight
(mean+standard error). Effects of drugs on
24 hour food intake (mean+standard error)
.
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tions and the groups showed similar patterns of change
although the EB groupbegan to gain weight several days
before the TAM or TAM+EB groups began to regain weight
(Figure 3A)
.
Food intake
Treatment also significantly reduced total food in-
take, £(3,32)=14.34, e<.001. TAM and TAM+EB both reduced
food intake relative to EB or oil. EB did not produce the
expected significant effect on total food intake relative
to oil (Figure 2B). TAM and TAM+EB produced immediate
reductions of food intake which continued for the duration
of the injections. Animals receiving EB showed an im-
mediate, transient reduction of food intake which lasted
about six days and then increased food intake to that of
controls (Figure 3B).
Carcass composition
Because of the differences of body weights among the
various groups the way in which the carcass components
were expressed affected the results. Both TAM and EB
produced nonsignificant effects on water and fat in the
expected direction. Concurrent administration of these
drugs increased these effects (Table 2).
Treatment produced a significant effect on grams of
water, £(3 , 31) =20.79, p<.0001, with the EB group reduced
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Table 2. Rat carcass composition from Experiment 2showing weight in grams, percent of carcass wet weight(wet percent), and percent of carcass dry weight (drypercent) (mean±standard error) . ^-^yni- vu
Water
Drug
Oil EB TAM TAM+EB
(n=9) (n=8) (n=9) (n=9)
169.7 151.3 bi4o.i ^137 4
±2.9 ±3.2 ±2.7 ±4.0
wet percent 60.6 62.0 62.4 ^63.
9
±0.7 ±0.9 ±0.6 +0.4
Fat
grams 39.1 329.1 326.8 ^21.0
±2.2 ±3.2 ±2.2 ±1.7
wet percent 13.9 11.8 11.9 a 9.7
±0.7 ±1.2 ±1.0 ±0.7
dry percent 35.2 30.8 32.6 a28.2
±1.2 ±2.2 ±2.4 ±2.4
Protein
grams 54.6 346.6 345.3 C38.2
±1.9 ±1.0 ±1.4 ±2.7
wet percent 19.5 19.1 20.2 22.7
±0.5 + 0.2 ±0.5 ±3.7
dry per cent 49.5 50.4 53.7 50.4
±1.1 ±1.3 ±1.5 ±2.9
a. differs from oil, p<.05.
b. differs from oil and EB, e<.05.
c. differs from oil, EB, and Tarn, p<.05.
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compared to the oil group and with the TAM and TAM+EB
groups reduced relative to both the EB and the oil groups.
When water was expressed as per cent of carcass wet weight
treatment produced a significant effect, £(3 , 31) =4.54,
U<.01, with only the TAM + EB group showing an increase in
water compared to the oil group.
Treatment also produced significant effects on fat
expressed as grams, £(3 , 31) =10.71
, e<.0001 , and as per
cent of carcass wet weight, £(3,31) =3.87, e<.02, but not
on fat expressed as per cent of dry weight. Grams of fat
were reduced relative to oil rats in those receiving EB or
TAM, and were reduced relative to oil or EB rats in those
receiving TAM+EB. The TAM+EB group also showed reductions
relative to the oil group in fat expressed as per cent of
carcass wet weight and of dry weight.
Protein was significantly affected by treatment only
wh3n expressed in grams, £(3,31) =12.98, p<.0001. Rats
receiving TAM or EB showed decreases relative to the oil
group while those receiving TAM+EB showed reductions rela-
tive to each of the other groups.
Bq^y length L£l£ indsit
There were no differences in initial body lengths
among treatments, but all drug treatment groups showed
reduced final body lengths compared to the oil group,
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Table 3. Body length, Lee index, and uterine weight ofrats from Experiment 2 (mean±standard error).
Drug
Oil EB TAM TAM+EB
Body length
(n= 9 y
)
f n =
\ n-
initial
(mm)
212 .3 210 .1 210 .4 209 .8
±1 .1 ±2 . 0 I z • ^
final
(mm)
^226
±u
.2
o
. o
220
±1
.0
.1
218
±2
.1
.0
217
±2
.0
.3
Lee index
initial 295 .3 297 .8 297 .7 297 .5
±2 .8 ±2 .3 ±1 .2 ±2 .1
final ^302
.7 b297 .0 292 .3 289 .3
±1 .4 ±1 .7 ±1 .8 ±1 .6
Uterine weight^ 572 .3 C1195 .0 611 .2 d759 .8
(mg) ±58 .4 ±51 .7 ±22 .1 ±40 .0
a. greater than EB, TAM, and TAM+EB, p<.05.
b. greater than TAM and TAM+EB ,, p< . 05
.
c. greater than oil, TAM, and TAM+EB, e<.05.
d. greater than oil and TAM, p<.05.
e. n=8 for EB group.
£(3,32) =6.04, p<.01 (Table 3). Lee indices also were not
different before injections began but were different fol-
lowing treatment, Kruskal-Wallis a(3)=20.32, e<.0001, with
the oil group greater than the three groups receiving
drugs and the EB group greater than the TAM or TAm+EB
groups (Table 3). These results indicate that both TAM
and EB tend to reverse the ovar iectomy-induced obesity.
Uterine w eight
Uterine weight was significantly affected by treat-
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ment, £(3 ,31) =38.32, e<.0001. The TAM group and the oil
group did not differ significantly, the TAM+EB group was
heavier than both, and the EB group was considerably
heavier than the other three groups (Table 3). These
results indicate that TAM was active as an antiestrogen in
at least one tissue.
White adipose tissue
The effects of TAM and of EB on parametrial WAT were
similar. Concurrent administration of the drugs increased
these effects. The weight of parametrial WAT was signifi-
cantly affected, £ (3 , 3 1) =3 .91 , £<.02, with the weights in
both the TAM and the TAM+EB groups reduced compared to the
oil group (Table 4). WAT expressed as per cent of
Table 4. Parametrial white adipose tissue results for
rats in Experiment 2 (mean±standard error).
Drug
White Adipose Tissue
Oil EB TAM TAM+EB
(n=9) (n=8) (n=9) (n=9)
weight 3293.9 ai862.6 ^1532. 6 b 918.I
(grams) ±276.9 ±224.5 ±315.0 ±315.0
per cent of body weight 1.016 ^0.662 ^0.583 ^0.366
±0.080 ±0.084 ±0.112 ±0.034
LPL activity 0.519 ao.l94 0.255 a0.075
(umol FFA/h/mg protein) ±0.109 ±0.042 ±0.151 ±0.025
a. differs from oil, p<.05.
b. differs from oil and EB, p<.05.
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body weight did not show significant differences. WAT LPL
activity was significantly affected, £(3,31) =3.69, p<.03,
with both the EB group and the TAM+EB group significantly
reduced compared to the oil group and the TAM group
showing a nonsignificant reduction.
Brown adipose tissue
EB produced no effects in BAT. TAM produced in-
creases in BAT weight and protein which were blocked or
Table 5. Brown adipose tissue values for rats inExperiment 2 (mean±standard error).
Drug
Brown Adipose Tissue
weight
(grams)
Oil
(n=9)
403 .3
±51.7
EB
(n=8)
382.8
±42.6
Tarn
(n=9)
426.3
±37.0
Tam+EB
(n=9)
298.2
±35.4
per cent of body weight 0.124
±0.015
0.134
±0.013
bo. 164
±0.015
0.118
±0.011
protein
(mg/pad)
38.1
±4.8
39.4
±5.5
^47.
9
±4.3
32.3
±4.2
protein
(ug/mg BAT)
95.6
±4.8
101.0
±5.0
^112.0
±5.0
108.2
±4.3
DNA
(ug/pad)
834.5
±135.3
894.9
± 95.6
968.9
±141.7
827.0
±100.1
DNA
(ug/mg BAT)
2.000
±0.125
2.379
±0.190
2.279
±0.262
^2.866
±0.243
LPL activity
(umol FFA/h/mg protein)
0.131
±0.023
0.153
±0.008
0.113
±0.009
0.139
±0.015
a. differs from oil, p<.05.
b. differs from Tam+EB, p<. 05.
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attenuated by EB. The weight of BAT did not differ signi-
ficantly among groups and the effect of treatment on the
weight of BAT expressed as per cent of body weight fell
slightly short of significance, £(3 , 3 1) =2.33
, p=.09, al-
though the TAM group was elevated compared to the TAM+EB
group in BAT as per cent of body weight (Table 5).
Similar results occurred for mg of protein per BAT pad,
£(3,31)=1.87, E=.16, with the TAM group elevated relative
to the TAM + EB group. Protein as ug per mg of BAT was also
short of significance, £(3,31)=2.41, p=.09 with the TAM
group elevated relative to the oil group. The ug of DNA
per pad did not differ significantly among groups, however
the ug of DNA per mg BAT did, £(3 , 3 1) =3 .12
, p<.05, with
the TAM+EB group elevated compared to the oil group.
There were no significant differences in LPL activity
among the groups.
Qyygen consumption
While EB produced the expected increase in oxygen
consumption on the first day after injections began this
group then showed reduced oxygen consumption. This result
is quite different from those of Laudenslager , et al.
(1980, 1982) who found continued elevation of oxygen con-
sumption in response to estradiol. Drug treatment did not
have a significant effect on oxygen consumption as a
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DAYS AFTER FIRST INJECTION
Figure 4. Effect of drugs on oxygen consumption
(ml 02/min/kg«'75) as percent of baseline(mean+standard error).
percent of baseline values (using ml 02/min/kg-'75) , but
there was a decrease in oxygen consumption over days,
£(4,128)=17.00, p<.0001. The time by drug interaction was
significant, £(12,128) =2.76, p<.01. The interaction was
due to an increase on the first day after injections began
in the EB, TAM, and TAM+EB groups
relative to the oil group with both the EB and the TAM+EB
groups decreasing subsequently. The TAM group stayed at
or above the level of the oil group throughout (Figure 4.)
CHAPTER IV
EXPERIMENT 3
Because of the unexpected effect of EB on oxygen
consumption in Experiment 2 it was decided to compare the
effects of brief daily food deprivation with those of
liMiJiffl feeding on various measures in ovar iectomized
animals receiving oil, EB, or TAM. Because both EB and
antiestrogens have been shown to affect utilizable fuels
in blood, blood was collected for analysis.
Methods
Animals
Animals weere treated as in Experiments 1 and 2
except as noted below. Following ovariectomy the animals
were divided into six groups (n=5 or 6) which were
balanced for body weight and food intake and the groups
were randomly assigned to experimental conditions. The
animals weighed between 351 and 468 grams at the start of
injections 90 days after ovariectomy.
Drugs
Tamoxifen citrate (Stuart Pharmaceutical, Wilmington,
DE) and estradiol benzoate (EB, Shering Corporation,
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Bloomfield, NJ) were dissolved in sesame oil to produce a
full dose in .1 ml.
Procednrf
Animals each received either oil, 2 ug EB, or 250 ug
TAM. Three groups, each receiving one of the above treat-
ments, received food ^ libituin throughout the study,
while the other three groups had food removed approx-
imately six hours before lights-out and returned approxi-
mately one hour before lights-out starting on the first
day of injections. Water was available ad libitum at all
times throughout the experiment. Injections were given
daily approximately six hours before lights-out, and every
third day body weight and food intake were measured at
this time.
The animals were divided into three groups composed
of equal numbers of animals from each experimental group.
Injections began on three consecutive days and all mea-
sures were recorded in terms of number of days of injec-
tions .
Prior to initiation of the injections, all animals
were adapted to the Plexiglas chambers used for measuring
oxygen for 30 minutes per day for seven days.
Resting oxygen consumption was measured as described
in Experiment 2 every third day beginning two days before
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the start of injections. Three days after the last oxygen
measurement and at the same time of day as testing the
animals were decapitated and blood was collected. The
blood was centrifuged and the serum prepared appropriately
for the various analyses and then frozen for later
analysis
.
Plasma glucose was analyzed color imetr ically using
Sigma Kit #635. Total glycerides were assayed fluoro-
metrically by the method of Buccolo and David (1973).
Free fatty acids were measured color imetr ically by the
method of Soloni and Sardinia (1973). Serum albumin was
measured color imetr ically using a modification of the
method of Rodkey (1964).
Pat^ anal ysis
Total food intake and final body weight expressed as
a percent of initial body weight were calculated and
expressed as in Experiment 1. The above data and the
blood measures were analysed by two-way analysis of var-
iance (drug (3) x feeding (2)) followed by the Duncan's
multiple range test with IDAP (Wiedman & Hosmer, 1983).
Oxygen consumption expressed as per cent of baseline was
analyzed by a mixed analysis of variance (drug (3) x
feeding (2) x repeated measure (4)) using BMDP4V. A value
of p<.05, two-tailed, was considered significant.
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Results
Body we ight
Both oil and EB combined with the five-hour food
deprivation to produce unexpected results. Deprivation
slightly reduced body weight in the oil group and at-
tenuated the EB-induced reduction of weight. A signifi-
cant main effect of drug on final body weight expressed as
percent of initial body weight was found, £(2,28) =20.00,
p<.0001 with TAM reducing percent body weight compared to
EB and to oil and with EB reducing per cent body weight
compared to oil. There was no effect of feeding con-
dition. The drug x feeding condition interaction
approached significance, F(2,28) =2.80, p<.08. Both TAM
groups were lighter than both oil groups and the EB re-
stricted group, the EB ad lib groups was lighter than both
oil groups, and the EB restricted group was lighter than
the oil M lib group (Figure 5A).
Food intake
Five-hour food deprivation produced a striking and
inexplicable reduction of food intake in the oil group and
eliminated or attenuated the reduction expected in the EB
group. It did not affect feeding in the TAM group. There
was a significant main effect of drug on total food intake
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Figure 5. A. Effects of drug and feeding
condition on final body weight as percent of
initial body weight (mean+standard error). B.
Effects of drug and feeding condition on total
food intake (mean+standard error).
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£(2,28)=7.08, E<.01, with both TAM and EB reducing food
intake relative to oil, but not differing significantly
from each other. There was no effect of feeding condi-
tion. There was a significant drug x food interaction,
£(2,28)=4.72, e<.02 with the oil ad li^ group eating
significantly more than all other groups except the EB
restricted group which did not differ significantly from
any of the groups (see Figure 5B).
Oxygen consiimptioii
There was no main effect of either drug or feeding
condition on oxygen consumption expressed as a per cent of
baseline and the drug x feeding condition interaction also
was not significant. There was a significant effect of
time, Z(3,84) =4.80, p<.004, but none of the possible
interactions with drug or feeding condition were signifi-
cant. The patterns of oxygen consumption of the food
restricted groups did resemble those seen in Experiment 2
(Figure 6) while the pattern shown by the EB 3^ l ib group
more closely resembled the results found by Laudenslager
,
et. al. (1980, 1982).
Blood analy sis
The main effect of drug on glucose fell short of
significance, £(2 ,28) =2.60 , e=.09. The main effect of
feeding condition on glucose and the drug x feeding condi-
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DAYS AFTER FIRST INJECTION
Figure 6. Effects of drugs and feeding condi-
tion on oxygen consumption (ml O2/min/kg-'^S) as
percent of baseline (mean) (standard errors omit-
ted for clarity). Solid symbols represent food-
deprived groups and open symbols represent ad
lib , groups.
tion interaction were not significant (Table 6). The drug
main effect on free fatty acids was not significant, but
feeding condition did produce a significant effect,
£(2,28) =7.50, E<.02, with restriction elevating free fatty
acids. The drug x feeding condition interaction was not
significant (Table 6). There were no significant effects
on total glycerides (Table 6). The drug main effect on
serum albumin was significant, £(2,28) =80.00, e<.0001 .
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Table 6. Analysis of blood of rats from Experiment 3
showing glucose, free fatty acids (FFA), total glycerides
(TG) (triglycerides plus free glycerol), and serum albumin
(mean+ standard error).
Oil EB
"PAM
ad lib rest, ad lib rest, ad lib rest.(n=5) (n=5) (n=6) (n=6) (n=6) (n=6)
Glucose 135.5 132.6 109.4 118.7 109 4 123 0(mg/lOOml) ±9.8 ±10.3 ±6.9 ±10.1 ±6.0 lll'.l
,
0.441 0.535 0.449 ^0.708 0.478 0.607(umol/ml) ±0.070 ±0.078 ±0.078 ±0.071 ±0.086 ±0.050
,
,
2 .29 1 . 80 1.86 2.26 1.96 1.80(umol/ml) ±0.49 ±0.30 ±0.24 ±0.36 ±0.43 ±0.32
Albumin 26.9 28.9 ^31.1 b39.i 28.0 27.4(mg/ml) ±1.3 ±0.5 ±0.9 ±0.8 ±1.0 ±1.0
a. greater than all M lih groups, p<.05.
b. greater than both oil and both TAM groups, p<.05.
with estradiol increasing albumin above the levels of the
oil and TAM groups. The main effect of feeding condition
was not significant and the drug x feeding condition
interaction was not significant (Table 6).
CHAPTER V
DISCUSSION
TAM when given alone produced effects on food intake,
body weight, and body composition which are similar to
those produced by EB as has been reported for other anti-
estrogens (for example, Gray & wade, 1981), The 50 ug
dose of TAM produced nearly maximal effects with the
administration of 5 times (250 ug) or 20 times (1000 ug)
this dose producing only small additional effects.
The data from these experiments are consistent with
TAM's acting via the estrogen receptor. Since both TAM
and EB bind to the estrogen receptor, when both produce
similar effects the simplest explanation is that both are
acting via the estrogen receptor. However, with the ex-
ception of effects in which concurrent application of TAM
and EB blocked effects of TAM, the role of a specific
antiestrogen binding substance cannot be ruled out by
these experiments. In Experiment 2 concurrent administra-
tion of EB and TAM blocked a slight increase in protein as
a percent of carcass dry weight produced by TAM, blocked
the increase of BAT weight as percent of body weight
produced by TAM, and attenuated the increase in ug protein
per mg BAT produced by TAM.
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Concurrent administration of TAM and EB produced
nearly additive effects on food intake, water as percent
of body weight, fat as percent of body weight, and Lee
index. If both TAM and EB were maximally potent alone,
this would imply that they were operating through separate
mechanisms. The food restriction in Experiment 2 virtual-
ly eliminated the EB effect on food intake. All the
measures just mentioned appear to be affected by intake,
the additivity may be a result of the attenuation of the
EB effects. Several measures— naso-anal length, para-
metrial WAT weight in grams and as percent of body weight,
and WAT LPL ac t i v i ty--whi ch appear to be independent of
food intake did not show this additivity.
In the M lib. conditions of Experiment 3, TAM and EB
had virtually identical effects on food intake and on body
weight. The five hour food restriction attenuated (Ex-
periment 2, Figure 2) or eliminated (Experiment 3, Figure
5) the reductions in food intake and body weight by EB but
did not alter the decreases produced by TAM. The five
hour food restriction did not eliminate the effects of EB
on various measures relating to body weight and composi-
tion (e.g. body weight, parametrial WAT weight, WAT LPL
activity, body length). Bowman, Leake, and Morris (1982)
found that .7 mg/kg of TAM (about 250 ug in a 350 g rat)
produced no increase in cell nuclear estrogen receptors in
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the hypothalamus of rats although this dose did produce
increases in estrogen receptors in pituitary and in
uterus. One possible explanation of the differences in EB
effects is that the five-hour food restriction altered
effects in the hypothalamus but did not directly affect
the periphery of the body. This possibility is
strengthened by the finding by Nunez, et al. (1980) that
hypothalamic implants of EB--which do decrease food
intake—did not affect WAT LPL activity, essentially the
obverse of the results in Experiment 2.
The results of Experiments 2 and 3 can aid in dis-
sociating some effects of EB from its effect on food
intake. In Experiment 3 the food intake and body weight
of the ^ lib. EB group were significantly reduced com-
pared to the 5^ lib. oil group and were essentially the
same as those of the ad lib. TAM group. In Experiment 2
the food intake of the EB group did not differ signifi-
cantly from the oil group, but the body weight of the EB
group was significantly reduced. This suggests that fac-
tors other than food intake were involved in the EB-
induced reduction of body weight as has been previously
demonstrated by Roy and Wade (1977) and Mueller and Hsaio
(1980)
.
The effects of EB on parametrial WAT weight and WAT
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LPL activity were very similar to those of TAM which
suggests that they are independent of food intake. The
effect of EB on naso-anal length was also similar to TAM
as well as TAM+EB suggesting independence from food in-
take. Mueller and Hsaio (1981) estimated that about 40
percent of the increased weight resulting from ovariectomy
was associated with skeletal growth. Thus effect on WAT
and on body growth may account for much of the weight
change not related to food intake.
The effects of EB and TAM on resting oxygen con-
sumption are quite different. Animals which were food
restricted in Experiments 2 and 3 and received EB showed
and initial increase in oxygen consumption followed by a
decrease, while those receiving TAM showed the initial
increase followed by continued high levels. In Experiment
3 the ^ li^. EB group showed continued high levels of
oxygen consumption as had been found by Laudenslager , et
al. (1980,1982), while the M lib'. TAM group was indis-
tinguishable from the ^ lib , oil group (an effect which
would be expected of a competitive estrogen antagonist in
the absence of estrogens). Concurrent administration of
TAM and EB did not appear to produce the effect expected
with antagonists. While the continued increase produced
by TAM was eliminated, the TAM+EB group was very similar
to the EB group rather than the oil group. This may be
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explained by EE's blocking the TAM effects in BAT plus
having an effect on oxygen consumption independently of
BAT.
The animals in these experiments were housed a tem-
peratures in the human comfort range so that BAT may play
only a small role in resting oxygen consumption. BAT
weight in grams did correlate slightly (r=.41) with oxygen
consumption in ml 02/min. EB had little or no effect on
the various measures in BAT in food restricted rats. The
lack of effect on BAT LPL activity is consistent with the
findings of Edens and Wade (1983). TAM, on the other
hand, increased BAT weight and BAT protein in food re-
stricted rats, but had no effect on DNA or BAT LPL activ-
ity. The TAM effects were blocked by concurrent admini-
stration of TAM and EB. These results could be consistent
with a slight role of BAT in the increased oxygen consum-
ption of the food restricted TAM groups in Experiments 2
and 3
.
Large variances caused partly by the small number of
animals make interpretation of effects on blood measures
difficult. Food restriction caused an increase of free
fatty acids in all three groups, a result which is con-
sistent with other reports on the effects of food re-
striction (see for example, Steffens, 1969). The various
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blood measures showed only slight correlations with food
intake, body weight, or oxygen consumption, il's<.30.
One unexpected finding was the significant 35 to 40
percent increase of serum albumin in the two EB groups.
One cause of this could be interference in the assay by
blood globulins (Webster, 1974), however the samples were
read within three seconds of the addition of the bromo-
cresol green solution and Webster found that albumin
readings were stable for about 10 seconds. Peterson and
Spaziani (1971) showed that EB increases uptake of albumin
by uterus although it does not cause increases of uptake
in other tissues. Clark and Peck (1979) suggest that
albumin in intercellular fluid of uterus may serve as a
storage mechanism to concentrate estrogens. This could
provide a reason for increased production of albumin by
EB.
EB and TAM combined with M lib , food administration
or food restriction permit separation of some effects from
food intake, and may permit manipulations which will pro-
duce opposing effects. These combinations should be of
use for further investigation of general factors, as well
as estrogen receptor mediated effects, on food intake,
body composition, and metabolic rate.
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